These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30697478)

  • 1. Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of
    Liew SM; Rajasekaram G; Puthucheary SA; Chua KH
    PeerJ; 2019; 7():e6217. PubMed ID: 30697478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
    Shahri FN; Izanloo A; Goharrizi MASB; Jamali A; Bagheri H; Hjimohammadi A; Ardebili A
    Int Microbiol; 2022 Nov; 25(4):709-721. PubMed ID: 35697891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of T3SS (exoS, exoT, exoU and exoY), susceptibility pattern and MIC of MDR-Pseudomonas aeruginosa from burn wounds.
    Ullah R; Amir M; Anjum S; Ur Rehman M; Noorul Hasan T; Sajjad Naqvi S; Faryal R; Ali Khan H; Khadija B; Arshad N; Rashid Z; Yousaf M; Ammad M; Mazhar K
    J Infect Dev Ctries; 2023 Aug; 17(8):1130-1137. PubMed ID: 37699096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents.
    Fujimura T; Anan N; Sugimori G; Watanabe T; Jinushi Y; Yoshida I; Yamano Y
    Int J Antimicrob Agents; 2009 Dec; 34(6):523-8. PubMed ID: 19748767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
    Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance and genomic rep-PCR fingerprints of Pseudomonas aeruginosa strains from animals on the background of the global population structure.
    Serrano I; Oliveira M; Santos JP; Bilocq F; Leitão A; Tavares L; Pirnay JP; De Vos D
    BMC Vet Res; 2017 Feb; 13(1):58. PubMed ID: 28222788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
    Karlowsky JA; Draghi DC; Jones ME; Thornsberry C; Friedland IR; Sahm DF
    Antimicrob Agents Chemother; 2003 May; 47(5):1681-8. PubMed ID: 12709340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran.
    Saderi H; Owlia P
    Iran J Pathol; 2015; 10(4):265-71. PubMed ID: 26351496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance patterns of Pseudomonas aeruginosa to carbapenems and piperacillin/tazobactam.
    Mokaddas EM; Sanyal SC
    J Chemother; 1999 Apr; 11(2):93-6. PubMed ID: 10326738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity Patterns, Plasmid Profiles and Clonal Relatedness of Multi-Drug Resistant
    Odoi H; Boamah VE; Duah Boakye Y; Dodoo CC; Agyare C
    Environ Health Insights; 2022; 16():11786302221078117. PubMed ID: 35185334
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
    Jones RN; Stilwell MG; Rhomberg PR; Sader HS
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):331-4. PubMed ID: 19822273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections.
    Sader HS; Castanheira M; Duncan LR; Mendes RE
    Int J Infect Dis; 2021 Dec; 113():279-281. PubMed ID: 34670144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
    Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G
    Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan.
    Tarazi YH; Abu-Basha E; Ismail ZB; Al-Jawasreh SI
    Acta Trop; 2021 May; 217():105859. PubMed ID: 33582141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of NDM - 1 in the Clinical Isolates of Pseudomonas aeruginosa in India.
    Khajuria A; Praharaj AK; Kumar M; Grover N
    J Clin Diagn Res; 2013 Jul; 7(7):1328-31. PubMed ID: 23998058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.